Improving the Outcomes of Immunocompromised Patients With Coronavirus Disease 2019

Recent case studies have highlighted the fact that certain immunocompromised individuals are at risk for prolonged SARS-CoV-2 replication, intrahost viral evolution of multiply-mutated variants, and poor clinical outcomes. The immunologic determinants of this risk, the duration of infectiousness, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Haidar, Ghady, Mellors, John W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Online Only Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135839/
https://www.ncbi.nlm.nih.gov/pubmed/33949644
http://dx.doi.org/10.1093/cid/ciab397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135839/
https://www.ncbi.nlm.nih.gov/pubmed/33949644
http://dx.doi.org/10.1093/cid/ciab397

Ejemplares similares